European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update

2019/08/20 by Marko Babjuk, Maximilian Burger, Eva M. Compérat +21 · 1 citation
Medicine · #Bladder and Urothelial Cancer Treatments #Esophageal Cancer Research and Treatment #Urinary and Genital Oncology Studies

paper · doi:10.1016/j.eururo.2019.08.016

openalex publication_date 2019/08/20 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/03

Citations

• Discrepancy between Clinical and Pathologic Stage: Impact on Prognosis after Radical Cystectomy
• Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non–muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review

Cited by

• Medical gas plasma augments bladder cancer cell toxicity in preclinical models and patient-derived tumor tissues